| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 09/08/2010 | EP2024367B1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
| 09/08/2010 | EP1807431B1 Pyrrolo[1,2-d][1,2-4]triazine as inhibitors of c-jun n-terminal kinases (jnk) and p-38 kinases |
| 09/08/2010 | EP1771451B1 (1s,5s)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |
| 09/08/2010 | EP1644376B1 PYRROLO 3,4-c PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS |
| 09/08/2010 | EP1478624B1 Chemical compounds |
| 09/08/2010 | EP1320531B1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/08/2010 | EP1263759B1 Azaindoles |
| 09/08/2010 | EP0882717B1 Nitrogenous heterocyclic compounds |
| 09/08/2010 | CN1798746B Reverse-turn mimetics and method relating thereto |
| 09/08/2010 | CN1732154B Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 09/08/2010 | CN101827850A Novel compounds of reverse turn mimetics and the use thereof (2) |
| 09/08/2010 | CN101827849A Novel compounds of reverse turn mimetics and the use thereof (1) |
| 09/08/2010 | CN101827848A 2- [ (2-{phenylamino}-1H-pyrrolo [2, 3-d] pyrimidin-4-yl) amino] benzamide derivatives as iIGF-1R inhibitors for the treatment of cancer |
| 09/08/2010 | CN101824043A Compositions useful as inhibitors of protein kinases |
| 09/08/2010 | CN101824037A Preparation method of Januvia free base |
| 09/08/2010 | CN101824036A Salt of tetrahydroimidazo [1,5-a] pyrazine derivative, preparation method and pharmaceutical application thereof |
| 09/08/2010 | CN101823951A Process for the preparation of 2-ethyl-4,6-dimethylphenyl acetic acid |
| 09/08/2010 | CN101337963B Preparation of metal deuteroporphyrin compounds and method of use thereof |
| 09/08/2010 | CN101220034B Inverse V type ultra-gees alkali derivant electroluminescent organic material |
| 09/08/2010 | CN101130544B Chemical synthesis method for epinastine |
| 09/08/2010 | CN101058582B Method of preparing esopiclone intermediate 6-(5-chloro-2-pyridyl)-5-hydro-7-oxy-6,7-dihydro-5H-pyrrolo[3,4-b] pyrazine |
| 09/08/2010 | CN101044123B Pyrimidine derivative fused with nonaromatic ring |
| 09/07/2010 | US7791069 heating a metal-free monobicycloporphyrin compound or a copper complex thereof, to effect conversion to a monobenzoporphyrin compound; high field-effect mobility |
| 09/07/2010 | US7790902 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents |
| 09/07/2010 | US7790883 5-[[(2,3-difluorophenyl)methyl]thio]-7-[[(1R)-2-hydroxy-1-methylethyl]amino]-3-[2-(phenylsulfonyl)ethyl]thiazolo[4,5-d]pyrimidin-2-(3H)-one; protection of the thiazole nitrogen atom while reacting a 7- leaving group with an amine for an amination reaction to result in improved yields; efficiency |
| 09/07/2010 | US7790880 1-Vinylimidazoles ligands for iron and cobalt phthalocyanine complexes made by charging a powder phase in a closed vessel with nitrogen; excellent UV (Ultraviolet)-blocking effect together with low surface resistance; antistatic agents |
| 09/07/2010 | US7790879 Easily deformed in accordance with exerted force when the force is externally exerted and is high in its electric conductivity; used as a material of a flexible electronic device |
| 09/07/2010 | US7790741 Imidazothiazoles and imidazoxazoles |
| 09/07/2010 | US7790722 nicotinic receptor agonists such as 3-{[(1S,4S)-5-Methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]carbonyl}-1,2-benzisothiazole, used for the treatment of brain disorders |
| 09/07/2010 | US7790716 fatty acid biosynthesis inhibitors such as E)-3-(6-aminopyridin-3-yl)-N-methyl-N-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)acrylamide, used fro the treatment of bacterial infections; antibiotics |
| 09/07/2010 | US7790713 Inhibitors of interleukin-1β converting enzyme |
| 09/07/2010 | US7790712 and Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2 inhibitors, used for preventing or treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 09/07/2010 | US7790709 Heterocyclic compounds, methods of making them and their use in therapy |
| 09/07/2010 | US7789610 Methods for preventing/treating damage to sensory hair cells and cochlear neurons |
| 09/07/2010 | CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/07/2010 | CA2490326C Photodynamic therapy for vascular diseases |
| 09/07/2010 | CA2487426C Preparation of metal mesoporphyrin halide compounds |
| 09/07/2010 | CA2465079C Substituted thiene-3-ylsulphonylamino(thio)carbonyltriazolin(ethi)ones |
| 09/02/2010 | WO2010099159A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 09/02/2010 | WO2010098487A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors |
| 09/02/2010 | WO2010098367A1 Pyrimidopyrimidoindazole derivative |
| 09/02/2010 | WO2010098246A1 Organic electroluminescent element |
| 09/02/2010 | WO2010098002A1 Method for proving authenticity using naphthalocyanine compound, signal transduction method, polymer welding method, method for producing lithographic printing plate, printing ink, toner, heat-shielding material, and method for producing naphthalocyanine compound |
| 09/02/2010 | WO2010097576A1 1, 4-disubstituted piperidines as vasopressin receptor via antagonists |
| 09/02/2010 | WO2010097420A1 Process for the preparation of a chiral beta aminoacid derivative and intermediates thereof |
| 09/02/2010 | WO2010096854A1 Methods of modulating the activity of the mc3 and/or mc4 receptors and treatment of conditions related to these receptors |
| 09/02/2010 | WO2010096853A1 Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor |
| 09/02/2010 | WO2010044885A3 Soluble mtor complexes and modulators thereof |
| 09/02/2010 | WO2009092602A8 Anti-angiogenic compounds |
| 09/02/2010 | US20100222575 Polo-like kinase inhibitors |
| 09/02/2010 | US20100222573 Method of making porphyrins |
| 09/02/2010 | US20100222358 Octahydro-pyrrolo[3,4-b]pyrrole derivatives |
| 09/02/2010 | US20100222357 Indol-3-y-carbonyl-piperidin and piperazin-derivatives |
| 09/02/2010 | US20100222332 Pyrazolo-pyrazines derivatives used as g protein inhibitors |
| 09/02/2010 | US20100222330 New Compounds |
| 09/02/2010 | US20100222326 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders |
| 09/02/2010 | US20100222324 Substituted Indole Compounds |
| 09/02/2010 | US20100222323 Imidazopyrazine syk inhibitors |
| 09/02/2010 | US20100222320 Triazole derivatives for treating alzheimer's disease and related conditions |
| 09/02/2010 | US20100222316 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 09/02/2010 | US20100222303 Reverse-turn mimetics and method relating thereto |
| 09/02/2010 | US20100222218 Insecticidal heterocyclic carboxylic acid derivatives |
| 09/02/2010 | US20100221307 Antiviral agents, antiviral fibers and antiviral fiber structures |
| 09/02/2010 | US20100221251 Compositions and Methods for Treatment of Cancer |
| 09/02/2010 | US20100221215 Linked dibenzimidazole derivatives |
| 09/02/2010 | US20100221211 Pyridone-substituted-dihydropyrazolopyrimidinone derivative |
| 09/02/2010 | CA2753696A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors |
| 09/02/2010 | CA2750716A1 Pyrimidopyrimidoindazole derivative |
| 09/01/2010 | EP2223923A1 Process for the preparation of a chiral beta aminoacid derivative and intermediates thereof |
| 09/01/2010 | EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/01/2010 | EP2222757A2 Supramolecular handcuffs in polymeric architecture |
| 09/01/2010 | EP2222675A1 5-anilinoimidazopyridines and methods of use |
| 09/01/2010 | EP2222375A1 Improved process for the manufacture of anagrelide hidrochloride monhydrate |
| 09/01/2010 | EP1883639B1 Preparation of famciclovir and other purine derivatives |
| 09/01/2010 | EP1812439B1 Kinase inhibitors |
| 09/01/2010 | EP1469809B1 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
| 09/01/2010 | EP1028942B1 Dipeptide nitriles |
| 09/01/2010 | CN101821341A Modified colored pigments |
| 09/01/2010 | CN101821271A 6-substituted sulfonyl azabicyclo 3.2.1''octanes useful to inhibit 11 -hydroxysteroid dehydrogenase type-1 |
| 09/01/2010 | CN101821270A 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1 |
| 09/01/2010 | CN101821269A 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 2 |
| 09/01/2010 | CN101821268A Tetracyclic compounds for the treatment of hepatitis c |
| 09/01/2010 | CN101821267A Compounds for the treatment of hepatitis c |
| 09/01/2010 | CN101820881A Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treament of inflammation |
| 09/01/2010 | CN101817833A DPP-IV inhibitor |
| 09/01/2010 | CN101817826A Ruthenium porphyrin complex and preparation method |
| 09/01/2010 | CN101817825A Bi-dihydroxy ethylene urea, derivatives, preparation method and application thereof |
| 09/01/2010 | CN101817824A Trapidil and preparation method thereof |
| 09/01/2010 | CN101817823A Preparation method of 4,7-diazaindole and 5-site substitute thereof |
| 09/01/2010 | CN101816659A Anti-tumor medicament |
| 08/31/2010 | USRE41614 Synthetic analogs of ecteinascidin-743 |
| 08/31/2010 | US7786313 Heating a mixture of p-tolunitrile and p-octadecylthiobenzonitrileina solution of sodium tert-amyloxide and ferric chloride; addingsuccinic acid di-tert-amyl ester; cyclization; red pigments;cosmetics; lipsticks; plastics; shades/hues |
| 08/31/2010 | US7786306 Combining a solution comprising a polar, aprotic organic solvent and a mixture of isomers of 2-piperidin-2-yl-ethanol with an aliphatic alcohol solution containing an amino acid resolving agent selected from N-acetyl-L-leucine and N-acetyl-L-methionine; intermediates for cyclin-dependent kinases, CDK |
| 08/31/2010 | US7786162 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof |
| 08/31/2010 | US7786131 Anticancer agents; restenosis; atherosclerosis; skin disorders |
| 08/31/2010 | US7786118 Temozolomide FDA Orange book listed patent; water soluble, and storage stable formulation; L-threonine as dissolution enhancer |
| 08/31/2010 | US7786109 Tricyclic amide derivatives as modulators of H3 receptors |
| 08/31/2010 | US7786107 Treating neurodegenerative diseases, psychological disorders, pain, glaucoma, dru eye, dry mouth, Sjogren's syndrome, asthma, bradycardia, wound healing, gastrointestinal disorders; amide- or urea-functional 1,2,3,4-tetrahydrospiro[benzo[b]azepine-5,4'-piperidine] rings; selective as to subtypes M1-M5 |
| 08/31/2010 | US7786048 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 08/31/2010 | CA2450773C Method of the solid phase synthesis of pyrrole-imidazole polyamide |